COM:PROCEPT-BIOROBOTICS
PROCEPT BioRobotics
- Stock
Last Close
94.45
22/11 21:00
Market Cap
3.35B
Beta: -
Volume Today
361.21K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 7.08M - | 10.31M 45.62% | 20.84M 102.14% | 34.15M 63.83% | ||
average payables | 1.34M - | 1.63M 21.80% | 5.71M 249.34% | 11.45M 100.44% | ||
average receivables | 1.32M - | 3.01M 127.08% | 9.87M 228.22% | 31.82M 222.50% | ||
book value per share | -4.28 - | -5.21 21.53% | 16.21 411.37% | 4.44 72.61% | ||
capex per share | -0.23 - | -0.01 97.07% | -0.04 441.73% | -0.06 66.34% | ||
capex to depreciation | -5.09 - | -0.08 98.40% | -0.18 118.61% | -0.93 424.33% | -6.62 609.01% | |
capex to operating cash flow | 0.17 - | 0.00 97.23% | 0.01 114.23% | 0.03 219.65% | 0.23 607.11% | |
capex to revenue | -1.23 - | -0.03 97.55% | -0.02 43.12% | -0.04 105.95% | -0.19 423.31% | |
cash per share | 1.25 - | 2.85 127.75% | 18.47 548.02% | 5.00 72.94% | ||
days of inventory on hand | 303.00 - | 304.18 0.39% | 257.88 15.22% | 274.68 6.51% | 222.76 18.90% | |
days payables outstanding | 65.44 - | 50.45 22.91% | 39.80 21.10% | 90.37 127.07% | 75.64 16.30% | |
days sales outstanding | 65.02 - | 73.26 12.67% | 47.26 35.49% | 74.31 57.22% | 129.65 74.47% | |
debt to assets | 0.42 - | 0.43 2.49% | 0.16 63.07% | 0.25 55.71% | 0.19 23.37% | |
debt to equity | -0.18 - | -0.30 63.79% | 0.20 167.65% | 0.39 93.69% | 0.28 29.62% | |
dividend yield | ||||||
earnings yield | -0.03 - | -0.04 30.54% | -0.15 282.89% | -0.05 66.48% | ||
enterprise value | 1.39B - | 1.43B 2.77% | 161.94M 88.66% | 1.70B 949.64% | -179.70M 110.57% | |
enterprise value over ebitda | -33.94 - | -31.89 6.01% | -3.00 90.60% | -21.60 620.66% | 1.65 107.62% | |
ev to operating cash flow | -31.72 - | -29.55 6.85% | -2.82 90.44% | -21.15 648.67% | 1.66 107.87% | |
ev to sales | 225.28 - | 185.09 17.84% | 4.70 97.46% | 22.66 382.37% | -1.32 105.82% | |
free cash flow per share | -1.53 - | -1.38 9.72% | -3.51 154.26% | -1.87 46.79% | ||
free cash flow yield | -0.04 - | -0.03 9.72% | -0.14 326.37% | -0.05 67.97% | ||
graham net net | -4.75 - | -5.80 22.04% | 14.82 355.55% | 3.05 79.44% | ||
graham number | 11.06 - | 13.93 25.96% | 37.15 166.64% | 14.51 60.95% | ||
income quality | 1.04 - | 0.91 12.65% | 0.96 5.06% | 0.92 3.72% | 1.02 10.58% | |
intangibles to total assets | 0.04 - | 0.02 56.62% | 0.01 67.67% | 0.00 8.04% | 0.00 37.70% | |
interest coverage | -60.15 - | -9.09 84.89% | -9.32 2.60% | -15.57 67.07% | 27.33 275.45% | |
interest debt per share | 0.80 - | 1.71 112.33% | 3.64 112.81% | 1.86 48.89% | ||
inventory turnover | 1.20 - | 1.20 0.39% | 1.42 17.95% | 1.33 6.11% | 1.64 23.31% | |
invested capital | -0.18 - | -0.30 63.79% | 0.20 167.65% | 0.39 93.69% | 0.28 29.62% | |
market cap | 1.41B - | 1.47B 4.62% | 412.16M 72.03% | 1.84B 347.49% | ||
net current asset value | -155.10M - | -198.61M 28.06% | 256.24M 229.02% | 160.37M 37.41% | 226.60M 41.30% | |
net debt to ebitda | 0.46 - | 1.01 120.72% | 4.63 357.03% | 1.84 60.34% | 1.65 10.36% | |
net income per share | -1.27 - | -1.66 30.54% | -3.79 128.33% | -2.11 44.32% | ||
operating cash flow per share | -1.30 - | -1.38 5.45% | -3.48 152.87% | -1.81 47.96% | ||
payables turnover | 5.58 - | 7.24 29.72% | 9.17 26.75% | 4.04 55.96% | 4.83 19.48% | |
receivables turnover | 5.61 - | 4.98 11.25% | 7.72 55.01% | 4.91 36.39% | 2.82 42.68% | |
research and ddevelopement to revenue | 2.13 - | 2.11 1.04% | 0.55 73.88% | 0.39 29.88% | 0.36 7.93% | |
return on tangible assets | -0.71 - | -0.47 34.22% | -0.19 60.41% | -0.30 63.38% | -0.26 13.67% | |
revenue per share | 0.18 - | 0.22 19.56% | 2.09 852.47% | 1.69 19.23% | ||
roe | 0.30 - | 0.32 7.41% | -0.23 173.33% | -0.47 103.31% | -0.38 20.57% | |
roic | 0.38 - | 0.43 14.04% | -0.17 140.42% | -0.29 66.21% | -0.28 1.56% | |
sales general and administrative to revenue | ||||||
shareholders equity per share | -4.28 - | -5.21 21.53% | 16.21 411.37% | 4.44 72.61% | ||
stock based compensation to revenue | 0.32 - | 0.28 12.88% | 0.11 60.89% | 0.14 25.14% | 0.14 1.95% | |
tangible asset value | -146.13M - | -184.92M 26.54% | 265.34M 243.49% | 195.59M 26.29% | 279.55M 42.92% | |
tangible book value per share | -4.28 - | -5.21 21.53% | 16.10 409.33% | 4.41 72.64% | ||
working capital | 43.95M - | 95.73M 117.84% | 309.93M 223.76% | 237.34M 23.42% | 304.64M 28.36% |
All numbers in (except ratios and percentages)